Trimethoprim-Sulfamethoxazole Prophylaxis in the Management of Chronic Granulomatous Disease
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Long-term oral antimicrobial prophylaxis is accepted practice in the management of patients with chronic granulomatous disease (CGD). Reports of adverse outcome with trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis in other patient groups, and the recent occurrence of several severe fungal infections in patients followed at the National Institutes of Health (NIH), prompted a review of the NIH experience to examine the incidence of nonfungal and fungal infections in CGD patients with and without TMP-SMX prophylaxis. Prophylaxis decreased the incidence of nonfungal infections from 7.1 to 2.4 per 100 patient-months in patients with autosomal CGD (P less than .01) and from 15.8 to 6.9 infections per 100 patient-months (P = .06) in X-linked CGD patients. There was no significant change in the incidence of fungal infection in CGD patients on TMP-SMX (1.5-0.3 fungal infections/100 patient-months in autosomal CGD and 1.7-0.2 fungal infections/100 patient-months in X-linked CGD patients). TMP-SMX prophylaxis is indicated for the management of patients with CGD and decreases the incidence of non-fungal infections without increasing the incidence of fungal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Successful Chemoprophylaxis for Pneumocystis carinii Pneumonitis
Hughes, W. T., Kuhn, S., Chaudhary, S., Feldman, S., Verzosa, M., Aur, R. J. A., Pratt, C., & George, S. L. (1977) · New England Journal of Medicine · doi:10.1056/nejm197712292972602 · Cited by 690
Successful Intermittent Chemoprophylaxis for Pneumocystis carinii Pneumonitis
Hughes, W. T., Rivera, G. K., Schell, M. J., Thornton, D., & Lott, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162604 · Cited by 398
Incidence, severity, and prevention of infections in chronic granulomatous disease
Mouy, R., Fischer, A., Vilmer, E., Seger, R., & Griscelli, C. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80693-6 · Cited by 258
Recent Advances in Chronic Granulomatous Disease
GALLIN, J. I., BUESCHER, E. S., SELIGMANN, B. E., NATH, J., GAITHER, T., & KATZ, P. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-5-657 · Cited by 232
Self-citationClinical Features and Current Management of Chronic Granulomatous Disease
Forrest, C. B., Forehand, J. R., Axtell, R. A., Roberts, R. L., & Johnston, R. B. (1988) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30619-1 · Cited by 92
Cited by
Genetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L., & Holland, S. M. (2000) · Medicine · doi:10.1097/00005792-200005000-00004 · Cited by 883
Self-citationResidual NADPH Oxidase and Survival in Chronic Granulomatous Disease
Kuhns, D. B., Alvord, W. G., Heller, T., Feld, J. J., Pike, K. M., Marciano, B. E., Uzel, G., DeRavin, S. S., Priel, D. A. L., Soule, B. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007097 · Cited by 568
Self-citationCommon Severe Infections in Chronic Granulomatous Disease
Marciano, B. E., Spalding, C., Fitzgerald, A., Mann, D., Brown, T., Osgood, S., Yockey, L., Darnell, D. N., Barnhart, L., Daub, J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1154 · Cited by 423
Self-citationGastrointestinal Involvement in Chronic Granulomatous Disease
Marciano, B. E., Rosenzweig, S. D., Kleiner, D. E., Anderson, V. L., Darnell, D. N., Anaya-O'Brien, S., Hilligoss, D. M., Malech, H. L., Gallin, J. I., & Holland, S. M. (2004) · Pediatrics · doi:10.1542/peds.114.2.462 · Cited by 418
Self-citationItraconazole to Prevent Fungal Infections in Chronic Granulomatous Disease
Gallin, J. I., Alling, D. W., Malech, H. L., Wesley, R., Koziol, D., Marciano, B., Eisenstein, E. M., Turner, M. L., DeCarlo, E. S., Starling, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021931 · Cited by 400
Self-citation
Metadata
- Authors
- Margolis, D. M., Melnick, D. A., Ailing, D. W., & Gallin, J. I.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-09-01
- Volume
- 162
- Issue
- 3
- Pages
- 723-726
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2116133014
- Cited by
- 261
- References
- 5
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.